it’s going through the FDA’s expedited trials right now and is expected to take a large part of the market making shareholders a fortune. Any ideas Travis?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I would also like to know what this is….
http://www.businessinsider.com/depression-medication-treatment-ketamine-2018-5
Not sure where you got the tease, but check the article above. JNJ, AGN, VTGN all seem to be on the Ketamine trail. VTGN got some expedited trials but they don’t seem to have the Nasal delivery that JNJ has. Didn’t look into AGN. JNJ is near a 52 week low. Suicide(depression) is number 7 according to the CDC as of 2015
http://www.investor.jnj.com/janssen-phase-3-study-programme-of-esketamine-nasal-spray-in-patients-with-treatment-resistant-depression-presented-for-the-first-time-in-europe
Looks like JNJ was expedited in 2013 on Ketamine. So sticking with JNJ but not sure this moves the needle for them regardless.
https://www.cdc.gov/healthequity/lcod/men/2015/all-males/index.htm
Me thinks the Might Thinkolator should be called in to solve this case…
Where do you guys get that depression is the 7th leading cause of men? Google shows Diabetes.
That’s what I’m seeing on the CDC site too – diabetes. And Eli Lilly bought a glucagon nasal spray from a small company back in 2015. As of last July it was still in trials, but showing great success. I’m going with Eli Lilly and Company (LLY)
What is this miracle mist?